Select a profile:

• Par Sterile Products, LLC
  • Anesthesia Business Consultants
  • B. Braun Medical Inc.
  • Dräger
  • Edwards Lifesciences
  • Grifols
  • MAQUET Medical Systems USA
  • Masimo
  • McMahon Publishing
  • Mindray
  • Pacira Pharmaceuticals, Inc.
  • Spacelabs Healthcare
  • TeamHealth Anesthesia
  • Teleflex
  •  

Par Sterile Products, LLC

“Providing patients and customers with uncompromising quality and value.”

Quality You Can Depend On

The legacy of Par Sterile Products reaches back to the birth of the American pharmaceutical industry at the turn of the 20th century. With a sterile manufacturing facility located in Rochester, Mich., Par Sterile Products possesses an unparalleled reputation for high-quality products and an impeccable record of regulatory compliance. Our iconic brands, such as Aplisol^® and Adrenalin^®, have been relied on by physicians and patients for decades. While proud of our heritage, we are even prouder of the great things we are accomplishing today. In an injectables world frequently plagued by compliance issues and product shortages, Par Sterile Products stands as a highly regarded partner with exemplary trade service levels and an impeccable record of regulatory compliance. Every week in America, more than 1 million Par prescriptions are dispensed, including Par Sterile Products. In return for the trust that is placed in us, we are committed to providing products of uncompromising quality. In fulfilling this mission, we deliver value to our customers and the physicians and patients who rely on us.

Partners for Health Care Excellence

Par Sterile Products, LLC, a subsidiary of Par Pharmaceutical, Inc., is at the forefront of developing, manufacturing, marketing and distributing safe, innovative and cost-effective branded and generic aseptic injectable pharmaceuticals that help improve patient quality of life. We also provide contract manufacturing services to our partners in the biopharmaceutical and pharmaceutical industry. Today, our company’s sales, together with Par Pharmaceutical, Inc., and its other subsidiaries, place it among the top five largest generic pharmaceutical companies in the United States. At Par Sterile Products, our most important resource is the talent and dedication of our nearly 500 employees, each of whom is part of a culture that values integrity, customer focus, teamwork and performance.

Promising Product Pipeline

Par Sterile Products currently markets a portfolio of 14 specialty injectable products, including Brevital^®, Dantrium^®, Pitocin^® and zoledronic acid. Since 2012, Par Sterile Products has launched nine new products. We possess one of the most promising new product pipelines in the injectable space, having developed a pipeline currently consisting of 34 products, 17 of which have already been submitted for FDA approval. We expect at least a half-dozen more ANDA filings before year end, fueled by our commitment to investment in research and development.

At Par Sterile Products, we are large enough to maintain a significant trade presence, yet agile enough to provide maximum attention to our customers, and we remain poised to continue our impressive track record of success. For more information, please visit www.parpharm.com.

PAR—People Achieving Results!

This corporate profile was reviewed and approved by Par Sterile Products, LLC .

Close